Vontobel Holding Ltd. Decreases Stock Position in Corteva, Inc. $CTVA

by · The Markets Daily

Vontobel Holding Ltd. cut its position in Corteva, Inc. (NYSE:CTVA – Free Report) by 6.7% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 113,795 shares of the company’s stock after selling 8,151 shares during the quarter. Vontobel Holding Ltd.’s holdings in Corteva were worth $7,696,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently made changes to their positions in the company. Gladwyn Financial Advisors Inc. bought a new stake in Corteva in the 2nd quarter valued at about $25,000. Total Investment Management Inc. purchased a new position in shares of Corteva in the second quarter worth about $27,000. Curat Global LLC raised its position in shares of Corteva by 93.7% in the second quarter. Curat Global LLC now owns 370 shares of the company’s stock valued at $28,000 after purchasing an additional 179 shares during the period. Maryland Capital Advisors Inc. purchased a new stake in shares of Corteva during the 2nd quarter valued at approximately $29,000. Finally, Twin Peaks Wealth Advisors LLC bought a new position in Corteva in the 2nd quarter worth approximately $29,000. Institutional investors own 81.54% of the company’s stock.

Corteva Price Performance

Shares of NYSE CTVA opened at $67.33 on Thursday. The firm has a market capitalization of $45.50 billion, a P/E ratio of 28.77, a P/E/G ratio of 1.52 and a beta of 0.74. The company has a quick ratio of 1.07, a current ratio of 1.58 and a debt-to-equity ratio of 0.07. The stock’s 50-day simple moving average is $64.83 and its two-hundred day simple moving average is $69.22. Corteva, Inc. has a twelve month low of $53.40 and a twelve month high of $77.41.

Corteva (NYSE:CTVA – Get Free Report) last issued its quarterly earnings results on Tuesday, November 4th. The company reported ($0.23) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.49) by $0.26. The firm had revenue of $2.62 billion during the quarter, compared to the consensus estimate of $2.47 billion. Corteva had a return on equity of 9.37% and a net margin of 9.19%.The company’s revenue for the quarter was up 6.5% on a year-over-year basis. During the same quarter last year, the company posted ($0.49) EPS. As a group, equities analysts anticipate that Corteva, Inc. will post 2.96 EPS for the current fiscal year.

Corteva Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Monday, December 15th. Stockholders of record on Monday, December 1st were issued a dividend of $0.18 per share. This represents a $0.72 dividend on an annualized basis and a dividend yield of 1.1%. The ex-dividend date of this dividend was Monday, December 1st. Corteva’s payout ratio is currently 30.77%.

Analyst Ratings Changes

A number of brokerages have issued reports on CTVA. Royal Bank Of Canada lowered their target price on shares of Corteva from $86.00 to $80.00 and set an “outperform” rating on the stock in a report on Friday, October 17th. JPMorgan Chase & Co. upgraded Corteva from a “neutral” rating to an “overweight” rating and set a $67.00 price target for the company in a research report on Thursday, October 2nd. Weiss Ratings reissued a “hold (c-)” rating on shares of Corteva in a report on Monday. Mizuho cut their target price on Corteva from $85.00 to $78.00 and set an “outperform” rating for the company in a research note on Wednesday, October 8th. Finally, Argus decreased their price target on Corteva from $83.00 to $80.00 and set a “buy” rating on the stock in a research report on Monday, October 13th. Sixteen investment analysts have rated the stock with a Buy rating and six have given a Hold rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $78.21.

Check Out Our Latest Stock Report on Corteva

Corteva Company Profile

(Free Report)

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.

See Also

Want to see what other hedge funds are holding CTVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Corteva, Inc. (NYSE:CTVA – Free Report).